13F reference period
n/a
Security Snapshot
Yarrow Bioscience, Inc. - Common Stock, $0.0001 par value (YARW) Institutional Ownership
CUSIP: 92941V407
13F Institutional Holders and Ownership History for Q3 2026
Institutions Reporting
Shares (Excl. Options)
n/a
Price
$18.60
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Symbol
- YARW on Nasdaq
- Shares outstanding
- 9,433,962
- SEC-reported price per share
- $18.60
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- YARW - Yarrow Bioscience, Inc. - Common Stock, $0.0001 par value is tracked under CUSIP 92941V407.
- 13F reference-period holder data is not available.
- 11 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder data for the Q2 2026 reference period is not available.
- Available periods remain in the history table; they do not substitute for the headline period.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
92941V407
13F reference period
n/a
13F holders
13D/G owners
11
CIK / CUSIP context first
YARW full holder history
Yarrow Bioscience, Inc. SEC filings
Yarrow Bioscience, Inc. company facts
Yarrow Bioscience, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 92941V407:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
11
Security
YARW
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Bellevue Group AG | 11% | $27,010,000 | 1,000,000 | Bellevue Group AG | 10 Sep 2026 | |||
| Invus Global Management, LLC | 7.2% | $26,237,250 | 675,000 | Raymond Debbane | 11 Sep 2026 | |||
| Logos Global Management LP | 11% | +8% | 286,308 | +3.5% | Logos Global Management LP | 31 Jul 2026 | ||
| venBio Global Strategic Fund V, L.P. | 10% | 279,340 | venBio Global Strategic Fund V, L.P. | 27 Jul 2026 | ||||
| PERCEPTIVE ADVISORS LLC | 10% | 266,756 | Perceptive Advisors LLC | 27 Jul 2026 | ||||
| Janus Henderson Group Ltd. | 10% | 266,712 | JANUS HENDERSON GROUP Ltd. | 31 Jul 2026 | ||||
| RTW Fund Group GP, LLC | 10% | 266,307 | RTW Fund Group GP, LLC | 27 Jul 2026 | ||||
| ORBIMED ADVISORS LLC | 10% | 266,306 | ORBIMED ADVISORS LLC | 27 Jul 2026 | ||||
| AI Biotechnology LLC | 6% | 178,180 | AI Biotechnology LLC | 27 Jul 2026 | ||||
| Zhang Xiaofan | 0.6% | 162,452 | Zhang Xiaofan | 13 Aug 2026 | ||||
| ADAR1 Capital Management, LLC | 8.8% | 59,000 | ADAR1 Capital Management, LLC | 30 Jun 2026 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
1
Headline period
n/a
Rows shown
1-1 of 1
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 20 | $450 | +$450 | $22.50 | 1 |